Annual Report 2023

NOTESTOTHE CONSOLIDATED FINANCIAL STATEMENTS For the year ended 31 December 2023 118 The United Laboratories International Holdings Limited Annual Report 2023 30. DEFERRED TAXATION (Continued) The Group’s unrecognised deductible temporary differences are as follows: 2023 2022 RMB’000 RMB’000 Tax loss carry forwards 545,818 544,361 During the years ended 31 December 2023 and 2022, no tax loss was expired. Included in unrecognised tax losses are losses of RMB6,060,000 (2022: RMB7,898,000) that will expire within five years, all other losses may be carried forward indefinitely. No deferred tax asset in respect of tax losses has been recognised because the amount of future taxable profit that will be available to realise such assets is uncertain. The unused tax losses will be expired as follows: 2023 2022 RMB’000 RMB’000 2023 – 6,924 2024 – 974 2025 6,060 – 6,060 7,898